Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.45 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL403360 | 0.88 | HDAC3 (0.49) | POLBLMNANPC1RAB9AHDAC3 | |
| SCHEMBL9489979 | 0.79 | L3MBTL1 (0.86) | L3MBTL1POLBLMNAKMT2AMEN1 | |
| SCHEMBL17294061 | 0.76 | MAPK1 (0.53) | L3MBTL1NPC1RAB9AHDAC1MAPK1 | |
| SCHEMBL9123165 | 0.75 | HDAC1 (0.66) | POLBLMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9124741 | 0.75 | HDAC1 (0.66) | POLBLMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6682073 | 0.75 | HDAC1 (0.66) | POLBLMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8811886 | 0.75 | HDAC1 (0.66) | POLBLMNANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL13577911 | 0.75 | L3MBTL1 (0.97) | L3MBTL1POLBLMNAKMT2AMEN1 | |
| SCHEMBL14679165 | 0.75 | L3MBTL1 (0.73) | L3MBTL1POLBLMNAKMT2AMEN1 | |
| SCHEMBL14679126 | 0.75 | L3MBTL1 (0.73) | L3MBTL1POLBLMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120020881-A1 | Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes | KIT, STS, TST | L3MBTL1 3296/4885POLB 2263/4885LMNA 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.